Increased schedule-induced polydipsia in the rat following subchronic treatment with MK-801

Emily R Hawken1, Nicholas J Delva, James N Reynolds

  • 1Centre for Neuroscience Studies, Queen's University, Kingston, ON K7L 3N6, Canada.

Schizophrenia Research
|August 20, 2010
PubMed

Insights

Researchers studied primary polydipsia in rats using MK-801 to model schizophrenia. Results showed MK-801 significantly increased schedule-induced polydipsia, suggesting a potential animal model for this condition.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Animal Models

Background:

  • Primary polydipsia, excessive thirst not due to medical conditions, affects over 20% of psychiatric inpatients.
  • This condition is particularly prevalent in individuals with schizophrenia.

Purpose of the Study:

  • To investigate the effects of an animal model of schizophrenia-like symptoms on schedule-induced polydipsia (SIP).
  • To test the hypothesis that subchronic MK-801 administration increases SIP acquisition.

Main Methods:

  • Young adult male rats were used to establish schedule-induced polydipsia (SIP) under food restriction.
  • Rats received subchronic injections of MK-801 (0.5 mg/kg twice daily for 7 days) or saline.

Main Results:

  • Subchronic MK-801 treatment significantly increased the acquisition of schedule-induced polydipsia (SIP) in rats.
  • Control animals treated with saline did not exhibit the same increase in SIP.

Conclusions:

  • The findings support the use of subchronic MK-801 administration as an animal model for studying polydipsia associated with schizophrenia.
  • This model may provide insights into the neurobiological mechanisms underlying excessive water intake in schizophrenia.

Related Concept Videos